Among the earliest biological alterations, amyloid-β (Aβ) accumulation and tau hyperphosphorylation (p-tau) remain central hallmarks of AD pathology, although they are now considered part of a broader, multifactorial network of disease processes [6]. The gene discussed is MAPT; the disease is Alzheimer disease.